Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rafael Bitzur"'
Autor:
Rafael Bitzur, Kyriakos E. Kypreos, Eleni A. Karavia, Eva Xepapadaki, George Panayiotakopoulos, Caterina Constantinou
Publikováno v:
Angiology. 70(3)
Clinical and epidemiological studies during the last 7 decades indicated that elevated low-density lipoprotein cholesterol (LDL-C) levels and reduced high-density lipoprotein cholesterol (HDL-C) levels correlate with the pathogenesis and progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c4142c59fa1059e4970a5f246fd41fb
https://pubmed.ncbi.nlm.nih.gov/29862840
https://pubmed.ncbi.nlm.nih.gov/29862840
Publikováno v:
Atherosclerosis. 287:e273
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59dd7b35c5d1412654eea356ac237ea9
https://doi.org/10.1016/j.atherosclerosis.2019.06.845
https://doi.org/10.1016/j.atherosclerosis.2019.06.845
Autor:
Yosef Kleinman, Hofit Cohen, Guido Grassi, Constantine Tsigos, Rafael Bitzur, Gianmaria Brambilla, Giuseppe Mancia, Avivit Cahn
Publikováno v:
Diabetes Care
Improving cardiovascular (CV) risk profile, by lowering elevated body weight, blood pressure (BP), plasma cholesterol, and blood glucose (BG) levels, is of relevance for decreasing fatal and nonfatal CV events in young and middle-aged patients (1–4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f86c74e8379a69c51ef06affb6fcdb6
https://doi.org/10.2337/dcs13-2021
https://doi.org/10.2337/dcs13-2021
Publikováno v:
Diabetes Care
Statins are considered very effective in reducing cardiovascular morbidity and mortality in high-risk patients. However, although adherence to statins improves morbidity and mortality (1), it remains suboptimal (2). One of the most important causes o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80af18aa6451f5672905a2bb860e6923
https://doi.org/10.2337/dcs13-2038
https://doi.org/10.2337/dcs13-2038
Autor:
Rafael Bitzur
Publikováno v:
Diabetes care. 39
The issue of statin-associated cognitive impairment has been a hot topic among both patients and health care providers, especially since the U.S. Food and Drug Administration (FDA) issued a statement regarding rare postmarketing reports of ill-define
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e08fd0de3438e8de725d86670b75218
https://pubmed.ncbi.nlm.nih.gov/27440840
https://pubmed.ncbi.nlm.nih.gov/27440840
Autor:
Shlomo Segev, Tomer Ziv-Baran, Shaye Kivity, Yechezkel Sidi, Rafael Bitzur, Ronen Brenner, Maayan Antebi, Elad Maor
Publikováno v:
European journal of internal medicine. 34
Background Metabolic syndrome and its components are severe global health issues that are increasing in frequency as the prevalence of obesity increases. Various studies have established a correlation between metabolic syndrome and diseases including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58d0700660a6f028f3295e9386a51dd
https://pubmed.ncbi.nlm.nih.gov/28038825
https://pubmed.ncbi.nlm.nih.gov/28038825
Publikováno v:
Diabetes Care
Diabetes carries a high risk of atherosclerosis, and cardiovascular disease, especially coronary heart disease (CHD) and stroke, is by far the leading cause of death among patients with type 2 diabetes. Although statins reduce the risk of major vascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c683ce5d8a5c9204d5b7e23422d5442
http://europepmc.org/articles/PMC2811435
http://europepmc.org/articles/PMC2811435
Publikováno v:
Diabetes Care
The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% (171 million) in the year 2000, and the projected number could rise to 4.4% (366 million) in 2030 (1). This rapid rise is mainly attributable to the increase of diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ee758ddd66b5111d7eef5151e0f51b
http://europepmc.org/articles/PMC2811473
http://europepmc.org/articles/PMC2811473
Autor:
Rafael, Bitzur, Yoseph, Rozenman, Shlomo, Vinker, Dror, Dikerl, Joseph, Shemesh, Amnon, Lahad, Dov, Gavishl, Dror, Harats, Hilla, KnobLer
Publikováno v:
Harefuah. 154(5)
Atherosclerosis is one of the leading causes of morbidity and mortality in the world, including in Israel. This document updates the clinical recommendations of the Israeli medical societies (The Society for Research, Prevention and Treatment of Athe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::005235235c498d857010c0002b263bc4
https://pubmed.ncbi.nlm.nih.gov/26168647
https://pubmed.ncbi.nlm.nih.gov/26168647
Autor:
Auryan Szalat, Dov Gavish, Ronen Durst, Avishay Ellis, Uche Ken Ibe, Vardiella Meiner, Ros Whittall, Osnat Eliav, Yaakov Henkin, Eran Leitersdorf, Bruno Hershkovitz, Dror Harats, Steve E. Humphries, Shoshi Shpitzen, Daniel Schurr, Rafael Bitzur, Marta Futema, Hilla Knobler, Ardon Rubinstein
Publikováno v:
Atherosclerosis. 257
Background and aims Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the genes for LDL receptor ( LDLR ), apolipoprotein B ( APOB ) and proprotein convertase subtilisin/kexin type9 ( PCSK9). The purpose of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0aad04313ca03d9ae34ebd0e1a0c83f
https://pubmed.ncbi.nlm.nih.gov/28104544
https://pubmed.ncbi.nlm.nih.gov/28104544